MedTrace Logo

Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema

NCT00570544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2008-08-14

No results posted yet for this study

Summary

To evaluate if tiotropium (Spiriva)induced bronchodilation of inspiratory capacity in patients with moderate to severe copd subjected to metronome paced hyperventilation induced dynamic hyperinflation is dependent upon the extent of underlying emphysema as determined by high resolution-thin section CT lung.

Conditions

Interventions

DRUG

tiotropium

18ug capsule daily for 30 days

Sponsors & Collaborators

Principal Investigators

  • Arthur F Gelb, MD · Arthur F Gelb Medical Corporation

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Completion
2005-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570544 on ClinicalTrials.gov